• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹泻伴溶血尿毒综合征患儿尿足细胞mRNA排泄:长期预后的潜在标志物

Urinary podocyte mRNA excretion in children with D+HUS: a potential marker of long-term outcome.

作者信息

De Petris Laura, Patrick Jilma, Christen Erica, Trachtman Howard

机构信息

Department of Pediatrics, Washington University, St. Louis, Missouri, USA.

出版信息

Ren Fail. 2006;28(6):475-82. doi: 10.1080/08860220600778902.

DOI:10.1080/08860220600778902
PMID:16928616
Abstract

BACKGROUND

Diarrhea-associated hemolytic uremic syndrome (D+HUS) causes acute renal failure and may lead to podocyte loss. Objective. To determine if the urinary mRNA excretion of podocyte proteins is detectable in children with D+HUS and if it is a biomarker of a poor long-term outcome.

METHODS

Patients were randomly selected from participants in the SYNSORB Pk trial. Urine samples were collected daily during the first week of hospitalization. Specimens were also obtained in healthy volunteers. Synaptopodin and nephrin mRNA levels were measured using real-time PCR.

RESULTS

Fifteen children, aged 4.9+/-2.8 years, were studied. Patients were categorized based on urinary mRNA levels into normal (marker:GAPDH<or=mean + SD) or high (marker:GAPDH>mean + SD) in controls. Twelve patients (80%) had increased urinary podocyte mRNA excretion; 11 (73%) had high synaptopodin and 5 (33%) had high nephrin mRNA levels. Follow-up data were available in 13/15 patients, all of whom had normal blood pressure, urinalysis, and serum creatinine concentration.

CONCLUSION

The isolation of podocyte mRNA from routine urine samples is feasible in children with D+HUS. Most patients have podocyturia based on synaptopodin and nephrin mRNA excretion. Larger studies with extended follow-up are required to determine the relationship of these biomarkers to long-term renal prognosis in D+HUS.

摘要

背景

腹泻相关性溶血尿毒综合征(D+HUS)可导致急性肾衰竭,并可能导致足细胞丢失。目的:确定在D+HUS患儿中是否可检测到尿中足细胞蛋白的mRNA排泄,以及它是否是长期预后不良的生物标志物。

方法

从SYNSORB Pk试验的参与者中随机选取患者。在住院的第一周每天收集尿液样本。也从健康志愿者中获取样本。使用实时PCR测量突触素和nephrin mRNA水平。

结果

研究了15名年龄为4.9±2.8岁的儿童。根据尿mRNA水平将患者分为对照组中正常(标志物:GAPDH≤平均值+标准差)或高(标志物:GAPDH>平均值+标准差)。12名患者(80%)尿足细胞mRNA排泄增加;11名(73%)突触素水平高,5名(33%)nephrin mRNA水平高。13/15名患者有随访数据,所有患者血压、尿常规和血清肌酐浓度均正常。

结论

从D+HUS患儿的常规尿液样本中分离足细胞mRNA是可行的。基于突触素和nephrin mRNA排泄,大多数患者存在足细胞尿。需要进行更大规模、更长随访期的研究来确定这些生物标志物与D+HUS长期肾脏预后的关系。

相似文献

1
Urinary podocyte mRNA excretion in children with D+HUS: a potential marker of long-term outcome.腹泻伴溶血尿毒综合征患儿尿足细胞mRNA排泄:长期预后的潜在标志物
Ren Fail. 2006;28(6):475-82. doi: 10.1080/08860220600778902.
2
Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.用于估计肾小球足细胞丢失的肾内和尿中足细胞相关分子的 mRNA 表达。
Ren Fail. 2010 Jan;32(3):372-9. doi: 10.3109/08860221003611737.
3
Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.糖尿病正常白蛋白尿患者足细胞标志物尿排泄增加。
Nephron. 2015;131(1):34-42. doi: 10.1159/000438493. Epub 2015 Sep 5.
4
Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.糖尿病肾病患者尿沉渣中足细胞相关分子的信使核糖核酸表达
Nephron Clin Pract. 2007;106(4):c169-79. doi: 10.1159/000104428. Epub 2007 Jun 26.
5
Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases.获得性蛋白尿疾病尿沉渣中肾小球足细胞标志物的信使核糖核酸表达
Clin Chim Acta. 2005 Nov;361(1-2):182-90. doi: 10.1016/j.cccn.2005.05.016.
6
Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury.腹泻伴溶血尿毒综合征中的尿中性粒细胞明胶酶相关脂质运载蛋白:一种新型肾损伤标志物。
Pediatr Nephrol. 2006 Jul;21(7):989-94. doi: 10.1007/s00467-006-0146-y. Epub 2006 Jun 1.
7
Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis.狼疮性肾炎患者尿沉渣中足细胞相关分子的信使核糖核酸表达
J Rheumatol. 2007 Dec;34(12):2358-64. Epub 2007 Nov 1.
8
Hemolytic uremic syndrome: defining the need for long-term follow-up.溶血性尿毒症综合征:明确长期随访的必要性。
Clin Nephrol. 1999 Dec;52(6):352-6.
9
Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.大肠杆菌O157溶血尿毒综合征5年后的蛋白尿和估算肾小球滤过率:最新情况
Am J Kidney Dis. 2008 Mar;51(3):435-44. doi: 10.1053/j.ajkd.2007.10.042.
10
Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial.口服志贺毒素结合剂对儿童腹泻相关性溶血尿毒综合征的影响:一项随机对照试验
JAMA. 2003 Sep 10;290(10):1337-44. doi: 10.1001/jama.290.10.1337.

引用本文的文献

1
Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome.预防腹泻相关性溶血尿毒综合征的干预措施。
Cochrane Database Syst Rev. 2025 Apr 25;4(4):CD012997. doi: 10.1002/14651858.CD012997.pub3.
2
Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome.预防腹泻相关性溶血尿毒综合征的干预措施。
Cochrane Database Syst Rev. 2021 Jul 5;7(7):CD012997. doi: 10.1002/14651858.CD012997.pub2.
3
Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome.
补体激活参与志贺毒素相关溶血尿毒综合征的病理生理过程。
Microorganisms. 2019 Jan 10;7(1):15. doi: 10.3390/microorganisms7010015.
4
Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.志贺毒素引发血管内皮细胞和足细胞损伤:补体激活的作用。
Pediatr Nephrol. 2019 Mar;34(3):379-388. doi: 10.1007/s00467-017-3850-x. Epub 2017 Dec 6.
5
Human Urine as a Noninvasive Source of Kidney Cells.人尿作为肾脏细胞的非侵入性来源。
Stem Cells Int. 2015;2015:362562. doi: 10.1155/2015/362562. Epub 2015 May 18.
6
ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome.水通道蛋白-2标准化的成人肾病综合征患者尿中nephrin和足突膜蛋白的ELISA分析
J Nephrol. 2014 Aug;27(4):411-7. doi: 10.1007/s40620-014-0066-z. Epub 2014 Apr 16.
7
Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.志贺毒素通过激活补体替代途径促进实验性溶血尿毒综合征中的足细胞损伤。
J Am Soc Nephrol. 2014 Aug;25(8):1786-98. doi: 10.1681/ASN.2013050450. Epub 2014 Feb 27.
8
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.志贺毒素相关溶血尿毒综合征:当前的分子机制与未来治疗方法
Drug Des Devel Ther. 2012;6:195-208. doi: 10.2147/DDDT.S25757. Epub 2012 Jul 19.
9
Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.大肠杆菌志贺毒素在肾脏疾病中的作用机制
Toxins (Basel). 2010 Dec 2;2(12):2769-2794. doi: 10.3390/toxins2122769.
10
Shiga toxin 2 targets the murine renal collecting duct epithelium.志贺毒素2靶向小鼠肾集合管上皮细胞。
Infect Immun. 2009 Mar;77(3):959-69. doi: 10.1128/IAI.00679-08. Epub 2009 Jan 5.